- Arumugam P, Partelli S, Coleman SJ, Cataldo I, Beghelli S, Bassi C, Wijesuriya N, Aleong JA, Froeling FE, Scarpa A et al: Ezrin expression is an independent prognostic factor in gastro-intestinal cancers. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2013, 17(12):2082-2091.
- Bria E, De Manzoni G, Beghelli S, Tomezzoli A, Barbi S, Di Gregorio C, Scardoni M, Amato E, Frizziero M, Sperduti I et al: A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status. Ann Oncol 2013, 24(3):693-701.
- Campa D, Rizzato C, Capurso G, Giese N, Funel N, Greenhalf W, Soucek P, Gazouli M, Pezzilli R, Pasquali C et al: Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2013, 45(2):95-99.
- Campos ML, Sanchez-Arevalo Lobo VJ, Rodolosse A, Gottardi CJ, Mafficini A, Beghelli S, Scardoni M, Bassi C, Scarpa A, Real FX: ICAT is a novel Ptf1a interactor that regulates pancreatic acinar differentiation and displays altered expression in tumours. The Biochemical journal 2013, 451(3):395-405.
- Capello M, Cappello P, Linty FC, Chiarle R, Sperduti I, Novarino A, Salacone P, Mandili G, Naccarati A, Sacerdote C et al: Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. Journal of hematology & oncology 2013, 6(1):67.
- Cavallini C, Lovato O, Bertolaso A, Pacelli L, Zoratti E, Zanolin E, Krampera M, Zamo A, Tecchio C, Cassatella MA et al: The TNF-family cytokine TL1A inhibits proliferation of human activated B cells. PLoS One 2013, 8(4):e60136.
- Cesano A, Perbellini O, Evensen E, Chu CC, Cioffi F, Ptacek J, Damle RN, Chignola R, Cordeiro J, Yan XJ et al: Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies. Haematologica 2013, 98(4):626-634.
- Chang DK, Jamieson NB, Johns AL, Scarlett CJ, Pajic M, Chou A, Pinese M, Humphris JL, Jones MD, Toon C et al: Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. J Clin Oncol 2013, 31(10):1348-1356.
- Chang DK, Jamieson NB, Scarpa A, McKay CJ, Biankin AV: Reply to G.F. Arroyo. J Clin Oncol 2013, 31(30):3843-3844.
- Dalla Pozza E, Lerda C, Costanzo C, Donadelli M, Dando I, Zoratti E, Scupoli MT, Beghelli S, Scarpa A, Fattal E et al: Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity. Biochimica et biophysica acta 2013, 1828(5):1396-1404.
- Di Costanzo F, Falconi M, Trodella L, Reni M, Scarpa A: Linee guida AIOM: Carcinoma del pancreas esocrino. AIOM document 2013.
- Falco A, Rosati A, Festa M, Basile A, De Marco M, d’Avenia M, Pascale M, Dal Piaz F, Tavano F, Di Mola FF et al: BAG3 is a novel serum biomarker for pancreatic adenocarcinomas. The American journal of gastroenterology 2013, 108(7):1178-1180.
- Giovinazzo F, Malpeli G, Zanini S, Parenti M, Piemonti L, Colombatti M, Valenti MT, Dalle Carbonare L, Scarpa A, Sinnett-Smith J et al: Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction. Cellular signalling 2013, 25(3):651-659.
- Gnoni A, Licchetta A, Scarpa A, Azzariti A, Brunetti AE, Simone G, Nardulli P, Santini D, Aieta M, Delcuratolo S et al: Carcinogenesis of pancreatic adenocarcinoma: precursor lesions. International journal of molecular sciences 2013, 14(10):19731-19762.
- Gruppo di lavoro AIOM – SIAPEC-IAP, Barbareschi M, Daidone MG, Lavitrano ML, Scarpa A, Pinto C, Clemente C, Ardizzoni A, Botti G, Bravo E et al: Bio-banche oncologiche a scopo di ricerca: Definizione, finalità, organizzazione, requisiti strutturali e tecnologici, consenso informato, privacy e modalità di accesso. AIOM-SIAPEC document 2013.
- Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, Niknafs N, Guthrie VB, Maitra A, Argani P et al: Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nature genetics 2013, 45(12):1470-1473.
- Lawlor RT, Sluss PM, Langer R, Sughayer MA, Igbe MA, Siddiqui K, De Blasio P, Duma B, Mendy M, Chabannon C et al: European, Middle Eastern, and African Society for Biopreservation and Biobanking (ESBB). 2012 Conference Session on Biobanking in Emerging Countries. Biopreserv Biobank 2013, 11(3):176-181.
- Oberg K, Casanovas O, Castano JP, Chung D, Delle Fave G, Denefle P, Harris P, Khan MS, Kulke MH, Scarpa A et al: Molecular pathogenesis of neuroendocrine tumors: implications for current and future therapeutic approaches. Clin Cancer Res 2013, 19(11):2842-2849.
- Partelli S, Gaujoux S, Boninsegna L, Cherif R, Crippa S, Couvelard A, Scarpa A, Ruszniewski P, Sauvanet A, Falconi M: Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). JAMA surgery 2013, 148(10):932-939.
- Pedica F, Ruzzenente A, Bagante F, Capelli P, Cataldo I, Pedron S, Iacono C, Chilosi M, Scarpa A, Brunelli M et al: A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. PLoS One 2013, 8(7):e68203.
- Rachakonda PS, Bauer AS, Xie H, Campa D, Rizzato C, Canzian F, Beghelli S, Greenhalf W, Costello E, Schanne M et al: Somatic mutations in exocrine pancreatic tumors: association with patient survival. PLoS One 2013, 8(4):e60870.
- Rosa R, Damiano V, Nappi L, Formisano L, Massari F, Scarpa A, Martignoni G, Bianco R, Tortora G: Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer. Br J Cancer 2013, 109(3):686-693.
- Sandhu SK, Fassan M, Volinia S, Lovat F, Balatti V, Pekarsky Y, Croce CM: B-cell malignancies in microRNA Emu-miR-17~92 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(45):18208-18213.
- Scarpa A, Fassan M, Rusev B, Luchini C, Capelli C: Pathologist’s role in the management of gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs). J Oncopathology 2013, 1(3):65-74.
- Scarpa A, Sikora K, Fassan M, Rachiglio AM, Cappellesso R, Antonello D, Amato E, Mafficini A, Lambiase M, Esposito C et al: Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel. PLoS One 2013, 8(11):e80478.
- Simbolo M, Gottardi M, Corbo V, Fassan M, Mafficini A, Malpeli G, Lawlor RT, Scarpa A: DNA qualification workflow for next generation sequencing of histopathological samples. PLoS One 2013, 8(6):e62692.